This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Janssen Biotech, Inc., Janssen Pharmaceutica Nv. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations by Inventor Hong Xie
Introduction
Hong Xie is a notable inventor based in Dresher, Pennsylvania, who has made significant contributions to the field of cancer treatment. With a total of three patents to his name, he has focused on developing innovative methods and formulations that target various types of cancers.
Latest Patents
Among his latest patents, one includes methods of treating cancers with antagonistic anti-PD-1 antibodies. This invention relates to the use of these antibodies, formulations, and drug products to effectively combat cancer. Another significant patent involves methods of treating prostate cancer with an anti-PSMA/CD3 antibody, which outlines bispecific monoclonal antibodies and their application in cancer treatment.
Career Highlights
Throughout his career, Hong Xie has worked with prominent companies in the pharmaceutical industry, including Janssen Biotech, Inc. and Janssen Pharmaceutica NV. His work in these organizations has allowed him to contribute to groundbreaking research and development in cancer therapies.
Collaborations
Hong Xie has collaborated with several professionals in his field, including Hillary Joy Millar Quinn and Kathryn Elizabeth Packman. These collaborations have further enhanced his research and innovation efforts.
Conclusion
In summary, Hong Xie is a distinguished inventor whose work in cancer treatment has led to valuable patents and collaborations. His contributions continue to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile